A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Crisaborole Impurity 56 | Crisaborole Impurity 56. Uses: For analytical and research use. Alternative Names: 2,4-dibromo-5-(4-cyanophenoxy)benzyl acetate. Molecular formula: C16H11Br2NO3. Mole weight: 425.07. Catalog: APB04555. |  |
| Crisaborole Impurity 57 | Crisaborole Impurity 57. Uses: For analytical and research use. Alternative Names: 4-(3-bromo-2-formylphenoxy)benzonitrile. Molecular formula: C14H8BrNO2. Mole weight: 302.12. Catalog: APB04556. | |
| Crisaborole Impurity 58 | Crisaborole Impurity 58. Uses: For analytical and research use. Alternative Names: 4-(3-bromo-2-(hydroxymethyl)phenoxy)benzonitrile. Molecular formula: C14H10BrNO2. Mole weight: 304.14. Catalog: APB04554. | |
| Crisaborole Impurity 59 | Crisaborole Impurity 59. Uses: For analytical and research use. Alternative Names: 2-bromo-6-(4-cyanophenoxy)benzyl acetate. Molecular formula: C16H12BrNO3. Mole weight: 346.18. Catalog: APB04552. | |
| Crisaborole Impurity 6 | Crisaborole Impurity 6. Uses: For analytical and research use. Alternative Names: 4-(3-formyl-4-hydroxyphenoxy)benzonitrile. Molecular formula: C14H9NO3. Mole weight: 239.23. Catalog: APB04581. | |
| Crisaborole Impurity 60 | Crisaborole Impurity 60. Uses: For analytical and research use. Alternative Names: 2-(4-cyanophenoxy)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate. Molecular formula: C22H24BNO5. Mole weight: 393.24. Catalog: APB04553. | |
| Crisaborole Impurity 61 | Crisaborole Impurity 61. Uses: For analytical and research use. Alternative Names: 4-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-4-yl)oxy)benzonitrile. Molecular formula: C14H10BNO3. Mole weight: 251.05. Catalog: APB04551. | |
| Crisaborole Impurity 62 | Crisaborole Impurity 62. Uses: For analytical and research use. Alternative Names: 4-(3-bromo-2-(dibromomethyl)phenoxy)benzonitrile. Molecular formula: C14H8Br3NO. Mole weight: 445.93. Catalog: APB04549. | |
| Crisaborole Impurity 63 | Crisaborole Impurity 63. Uses: For analytical and research use. Alternative Names: 2-bromo-5-(4-cyanophenoxy)benzyl acetate. CAS No. 2227126-09-0. Molecular formula: C16H12BrNO3. Mole weight: 346.18. Catalog: APB2227126090. | |
| Crisaborole Impurity 64 | Crisaborole Impurity 64. Uses: For analytical and research use. Alternative Names: 5-(4-cyanophenoxy)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate. CAS No. 2227126-13-6. Molecular formula: C22H24BNO5. Mole weight: 393.24. Catalog: APB2227126136. | |
| Crisaborole Impurity 65 | Crisaborole Impurity 65. Uses: For analytical and research use. Alternative Names: 4-(4-bromo-3-formylphenoxy)benzoic acid. Molecular formula: C14H9BrO4. Mole weight: 321.12. Catalog: APB04550. | |
| Crisaborole Impurity 66 | Crisaborole Impurity 66. Uses: For analytical and research use. Alternative Names: 1-(2-bromo-5-(4-cyanophenoxy)phenyl)-2-oxopropyl acetate. Molecular formula: C18H14BrNO4. Mole weight: 388.21. Catalog: APB04547. | |
| Crisaborole Impurity 67 | Crisaborole Impurity 67. Uses: For analytical and research use. Alternative Names: 4-(4-bromo-3-(hydroxymethyl)phenoxy)benzoic acid. Molecular formula: C14H11BrO4. Mole weight: 323.14. Catalog: APB04548. | |
| Crisaborole Impurity 68 | Crisaborole Impurity 68. Uses: For analytical and research use. Alternative Names: 5-(4-(aminomethyl)phenoxy)-2-bromobenzyl acetate. Molecular formula: C16H16BrNO3. Mole weight: 350.21. Catalog: APB04544. | |
| Crisaborole Impurity 69 | Crisaborole Impurity 69. Uses: For analytical and research use. Alternative Names: 5-(4-(acetamidomethyl)phenoxy)-2-bromobenzyl acetate. Molecular formula: C18H18BrNO4. Mole weight: 392.24. Catalog: APB04546. | |
| Crisaborole Impurity 7 | Crisaborole Impurity 7. Uses: For analytical and research use. Alternative Names: 4-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzoic acid. CAS No. 906673-43-6. Molecular formula: C14H11BO5. Mole weight: 270.05. Catalog: APB906673436. | |
| Crisaborole Impurity 70 | Crisaborole Impurity 70. Uses: For analytical and research use. Alternative Names: (5-(4-(aminomethyl)phenoxy)-2-bromophenyl)methanol. Molecular formula: C14H14BrNO2. Mole weight: 308.17. Catalog: APB04545. | |
| Crisaborole Impurity 71 | Crisaborole Impurity 71. Uses: For analytical and research use. Alternative Names: 4-(2-bromo-5-formylphenoxy)benzonitrile. Molecular formula: C14H8BrNO2. Mole weight: 300.97. Catalog: APB04542. | |
| Crisaborole Impurity 72 | Crisaborole Impurity 72. Uses: For analytical and research use. Alternative Names: 4-(2,4,6-tribromo-3-formylphenoxy)benzonitrile. Molecular formula: C14H6Br3NO2. Mole weight: 456.79. Catalog: APB04543. | |
| Crisaborole Impurity 73 | Crisaborole Impurity 73. Uses: For analytical and research use. Alternative Names: 4-(2-bromo-3-formylphenoxy)benzonitrile. Molecular formula: C14H8BrNO2. Mole weight: 300.97. Catalog: APB04541. | |
| Crisaborole Impurity 74 | Crisaborole Impurity 74. Uses: For analytical and research use. Alternative Names: 4-(3-(hydroxymethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)benzonitrile. CAS No. 2250222-38-7. Molecular formula: C20H22BNO4. Mole weight: 351.20. Catalog: APB2250222387. | |
| Crisaborole Impurity 75 | Crisaborole Impurity 75. Uses: For analytical and research use. Alternative Names: 4-((1-methoxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile. CAS No. 2368899-47-0. Molecular formula: C15H12BNO3. Mole weight: 265.07. Catalog: APB2368899470. | |
| Crisaborole Impurity 76 | Crisaborole Impurity 76. Uses: For analytical and research use. Alternative Names: 3-(4-cyanophenoxy)benzyl acetate. Molecular formula: C16H13NO3. Mole weight: 267.28. Catalog: APB04540. | |
| Crisaborole Impurity 77 | Crisaborole Impurity 77. Uses: For analytical and research use. Alternative Names: 1-(4-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)phenyl)pentan-1-one. Molecular formula: C18H19BO4. Mole weight: 310.15. Catalog: APB04539. | |
| Crisaborole Impurity 78 | Crisaborole Impurity 78. Uses: For analytical and research use. Alternative Names: 4,4'-((1,1'-oxybis(1,3-dihydrobenzo[c][1,2]oxaborole-5,1-diyl))bis(oxy))dibenzonitrile. Molecular formula: C28H18B2N2O5. Mole weight: 484.07. Catalog: APB04538. | |
| Crisaborole Impurity 79 | Crisaborole Impurity 79. Uses: For analytical and research use. Alternative Names: 4-(4-bromo-3-(bromomethyl)phenoxy)benzonitrile. Molecular formula: C14H9Br2NO. Mole weight: 367.04. Catalog: APB04537. | |
| Crisaborole Impurity 8 | Crisaborole Impurity 8. Uses: For analytical and research use. Alternative Names: 4-((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzamide. CAS No. 1187188-59-5. Molecular formula: C14H12BNO4. Mole weight: 269.06. Catalog: APB1187188595. | |
| Crisaborole Impurity 8 | Crisaborole Impurity 8. Uses: For analytical and research use. Molecular formula: C16H13NO3. Mole weight: 267.28. Catalog: APB10453. | |
| Crisaborole Impurity 80 | Crisaborole Impurity 80. Uses: For analytical and research use. Alternative Names: 4-bromo-3-(1,3-dioxolan-2-yl)phenol. CAS No. 1160182-44-4. Molecular formula: C9H9BrO3. Mole weight: 245.07. Catalog: APB1160182444. | |
| Crisaborole Impurity 81 | Crisaborole Impurity 81. Uses: For analytical and research use. Alternative Names: 4-(4-bromo-3-(1,3-dioxolan-2-yl)phenoxy)benzonitrile. CAS No. 1217366-74-9. Molecular formula: C16H12BrNO3. Mole weight: 346.18. Catalog: APB1217366749. | |
| Crisaborole Impurity 82 | Crisaborole Impurity 82. Uses: For analytical and research use. Alternative Names: 4-(4-bromo-3-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)phenoxy)benzonitrile. CAS No. 943311-78-2. Molecular formula: C19H18BrNO3. Mole weight: 388.26. Catalog: APB943311782. | |
| Crisaborole (Standard) | Crisaborole (Standard) is the analytical standard of Crisaborole. This product is intended for research and analytical applications. Crisaborole (AN-2728) is a potent inhibitor of PDE4 and cytokine release; inhibit PDE4 with an IC50 of 0.49 μM. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AN-2728 (Standard); PF-06930164 (Standard). CAS No. 906673-24-3. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-10978R. |  |
| Crisamicin A | It is produced by the strain of Micromonospora purpureochromogenes subsp. lalotolerans. It only has activity against gram-positive bacteria. The activity of samicin C is stronger than Crisamicin A. Synonyms: (3aS)-5β,5'β-Dimethyl-10,10'-dihydroxy-3,3',3aβ,3'aβ,5,5',6,6',11,11',11bβ,11'bβ-dodecahydro-8,8'-bi[2H-furo[3,2-b]naphtho[2,3-d]pyran]-2,2',6,6',11,11'-hexaone; (3aS,3'aS,5S,5'S,11bS,11'bS)-3,3',3a,3'a,5,5',11b,11'b-Octahydro-10,10'-dihydroxy-5,5'-dimethyl-8,8'-bi[2H-furo[3,2-b]naphtho[2,3-d]pyran]-2,2',6,6',11,11'-hexone; CRS-A; (8,8'-Bi-2H-furo(3,2-b)naphtho(2,3-d)pyran)-2,2',6,6'11,11'-hexone,3,3',3a,3'a,5,5',11b,11'b-octahydro-10,10'-dihydroxy-5,5'-dimethyl-, (3aS-(3aalpha,5alpha,8(3aR*,5R*,11bR*),11balpha))-. CAS No. 95828-47-0. Molecular formula: C32H22O12. Mole weight: 598.51. |  |
| Crisamicin C | It is produced by the strain of Micromonospora purpureochromogenes subsp. lalotolerans. It only has activity against gram-positive bacteria. The activity of samicin C is stronger than Crisamicin A. Synonyms: CRS-C. CAS No. 100630-79-3. Molecular formula: C32H22O13. Mole weight: 614.51. | |
| Crisdesalazine | Crisdesalazine is a microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor potentially for the treatment of Alzheimer's type dementia, Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Arthritis, Depression, Diabetes and Pancreatitis. Synonyms: AAD-2004; Benzoic acid, 2-hydroxy-5-((2-(4-(trifluoromethyl)phenyl)ethyl)amino)-. CAS No. 927685-43-6. Molecular formula: C16H14F3NO3. Mole weight: 325.28. | |
| Crisdesalazine | Crisdesalazine (AAD-2004) is a microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor. Crisdesalazine acts as a potent free radical scavenger that directly neutralizes reactive oxygen species (ROS) including hydrogen peroxide, exerting neuroprotective effects against apoptosis and axonal damage. Crisdesalazine inhibits PGE2 production, mediates inflammatory responses, and promotes the conversion of macrophages from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype. Crisdesalazine is applicable to neuroprotection research in multiple sclerosis and spinal cord injury[1][2]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: AAD-2004. CAS No. 927685-43-6. Pack Sizes: 1 mg; 5 mg; 10 mg; 25 mg; 50 mg. Product ID: HY-105005. | |
| Crispine A | Crispine A. Group: Biochemicals. Alternative Names: 1,2,3,5,6,10b-Hexahydro-8,9-dimethoxypyrrolo[2,1-a]isoquinoline. Grades: Highly Purified. CAS No. 15889-93-7. Pack Sizes: 100mg, 250mg, 500mg, 1g, 2g. Molecular Formula: C14H19NO2. US Biological Life Sciences. |  Worldwide |
| Cristatic acid | It is produced by the strain of Albaterllus cristatus. It can resist bacillus, tumor and hemolysis. Synonyms: NSC338268; NSC 338268; Cristatic acid-1. CAS No. 80557-13-7. Molecular formula: C23H28O5. Mole weight: 384.46. | |
| Crizanlizumab | Crizanlizumab is a monoclonal antibody used for the prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD). Crizanlizumab binds to P-selectin, a cell adhesion molecule expressed on the surface of activated endothelial cells and platelets. By inhibiting P-selectin, crizanlizumab helps prevent the adhesion of sickle red blood cells to the endothelium and other blood cells, which is a key step in the initiation of VOCs in patients with SCD. It is indicated for the prevention of VOCs in patients with SCD. Vaso-occlusive crises are episodes of severe pain caused by the blockage of blood flow in small blood vessels, leading to tissue ischemia and organ damage. Crizanlizumab aims to reduce the frequency and severity of these painful episodes. Synonyms: Immunoglobulin G2, anti-(human P-selectin) (human-Mus musculus monoclonal SelG1 heavy chain), disulfide with human-Mus musculus monoclonal SelG1 light chain, dimer; Adakveo; Crizanlizumab-tmca; SEG 101; SelG 1. CAS No. 1690318-25-2. | |
| Crizanlizumab | Crizanlizumab is an anti-P-selectin monoclonal antibody. Crizanlizumab binds to P-selectin and blocks its interaction with P-selectin glycoprotein ligand 1 (PSGL-1). Crizanlizumab prevents vaso-occlusive crises (VOCs) and can be used for research of sickle cell disease[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: hSel001; SEG101. CAS No. 1690318-25-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9987. | |
| Crizotinib | Crizotinib (PF-02341066) is an ATP-competitive small-molecule tyrosine kinase inhibitor of c-MET (IC50: 8 nM) and ALK (IC50: 20 nM) receptors. Category: Active pharmaceutical ingredients. CAS No. 877399-52-5. Product ID: API877399525. Molecular formula: C21H22Cl2FN5O. Mole weight: 450.34. |  |
| Crizotinib | Crizotinib is a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). Crizotinib is a potential antitumor agent. Group: Biochemicals. Alternative Names: 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine; (R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H- pyrazol-4-yl)pyridin-2-ylamine; PF 02341066; PF 2341066; [3-[[ (R) -1- (2, 6-Dichloro-3-fluorophenyl) ethyl]oxy]-5-[1- (piperidin-4-yl) -1H-pyrazol-4-yl]pyridin-2-yl]amine. Grades: Highly Purified. CAS No. 877399-52-5. Pack Sizes: 10mg. US Biological Life Sciences. | Worldwide |
| Crizotinib | Crizotinib is an anti-cancer drug acting as an ALK (anaplastic lymphoma kinase) and ROS1 (c-ros oncogene 1) inhibitor. Uses: Antineoplastic agents. Synonyms: PF-02341066; PF 02341066; PF02341066. Grade: >98%. CAS No. 877399-52-5. Molecular formula: C21H22Cl2FN5O. Mole weight: 450.343. | |
| Crizotinib | Crizotinib (PF-02341066) is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. Crizotinib is also a ROS1 inhibitor. Crizotinib has effective tumor growth inhibition[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PF-02341066. CAS No. 877399-52-5. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-50878. | |
| Crizotinib acetate | Crizotinib, an orally bioavailable agent, belongs to the class of c-met/hepatocyte growth factor receptor (HGFR) tyrosine kinase inhibitors with potential antineoplastic activity. Category: Active pharmaceutical ingredients. Synonyms: PF02341066. CAS No. 877399-53-6. Product ID: API877399536. Molecular formula: C23H26Cl2FN5O3. Mole weight: 510.39. | |
| Crizotinib-d5 | Crizotinib-d5 is a deuterated compound of Crizotinib. Crizotinib has a CAS number of 877399-52-5. Crizotinib is an ATP-competitive small-molecule tyrosine kinases inhibitor of c-MET (IC50: 8 nM) and ALK (IC50: 20 nM) receptor. Category: Active pharmaceutical ingredients. CAS No. 1395950-84-1. Product ID: API1395950841. Molecular formula: C21H17D5Cl2FN5O. Mole weight: 455.37. | |
| Crizotinib-d5 | Crizotinib-d5 is the deuterium labeled Crizotinib. Crizotinib (PF-02341066) is an orally bioavailable, ATP-competitive ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. Crizotinib is also a ROS1 inhibitor. Crizotinib has effective tumor growth inhibition[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PF-02341066-d5. CAS No. 1395950-84-1. Pack Sizes: 1 mg. Product ID: HY-50878S. | |
| Crizotinib-[d5] | Crizotinib-d5 is a labelled Crizotinib, a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK). Crizotinib is a potential antitumor agent. Synonyms: Crizotinib D5; 3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl-d4)-1H-pyrazol-4-yl]-2-pyridinamine-d5; (R)-3-[1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl-d4)-1H-pyrazol-4-yl]pyridin-2-ylamine-d5; PF 02341066-d5; PF 2341066-d5. Grade: 95% by HPLC; 95% atom D. CAS No. 1395950-48-7. Molecular formula: C21H17D5Cl2FN5O. Mole weight: 455.37. | |
| Crizotinib hydrochloride | Crizotinib hydrochloride (PF-02341066 hydrochloride) is an orally bioavailable, selective, and ATP-competitive dual ALK and c-Met inhibitor with IC50s of 20 and 8 nM, respectively. Crizotinib hydrochloride (PF-02341066 hydrochloride) inhibits tyrosine phosphorylation of NPM-ALK and tyrosine phosphorylation of c-Met with IC50s of 24 and 11 nM in cell-based assays, respectively. It is also a ROS proto-oncogene 1 (ROS1) inhibitor. Crizotinib hydrochloride (PF-02341066 hydrochloride) has effective tumor growth inhibition[1][2][3]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: PF-02341066 hydrochloride. CAS No. 1415560-69-8. Pack Sizes: 10 mM * 1 mL in DMSO; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg; 500 mg. Product ID: HY-50878A. | |
| Crizotinib hydrochloride | Crizotinib is inhibitor of the c-Met kinase and the NPM-ALK. Crizotinib inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM). Crizotinib is useful in treatment of anaplastic large-cell lymphoma. Synonyms: PF-02341066 hydrochloride; PF 02341066 hydrochloride; PF02341066 hydrochloride. Grade: >98%. CAS No. 1415560-69-8. Molecular formula: C21H23Cl3FN5O. Mole weight: 486.8. | |
| Crizotinib hydrochloride | Crizotinib hydrochloride (PF-02341066 hydrochloride) is a novel inhibitor of anaplastic lymphoma kinase and c-Met, with IC50 values of 20 nM and 8 nM, respectively. Category: Active pharmaceutical ingredients. Synonyms: PF-02341066 hydrochloride. CAS No. 1415560-69-8. Product ID: API1415560698. Molecular formula: C21H23Cl3FN5O. Mole weight: 486.8. | |
| Crizotinib Impurity 10 | Crizotinib Impurity 10. Uses: For analytical and research use. Alternative Names: (R)-1-(2,6-dichloro-3-fluorophenyl)ethanol. CAS No. 330156-50-8. Molecular formula: C8H7Cl2FO. Mole weight: 209.04. Catalog: APB330156508. | |
| Crizotinib Impurity 11 | Crizotinib Impurity 11. Uses: For analytical and research use. Alternative Names: (R)-tert-butyl 4-(4-(6-amino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate. CAS No. 877399-51-4. Molecular formula: C26H30Cl2FN5O3. Mole weight: 550.45. Catalog: APB877399514. | |
| Crizotinib Impurity 12 | Crizotinib Impurity 12. Uses: For analytical and research use. Alternative Names: (R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine. CAS No. 877397-71-2. Molecular formula: C13H11Cl2FN2O. Mole weight: 301.14. Catalog: APB877397712. | |
| Crizotinib Impurity 13 | Crizotinib Impurity 13. Uses: For analytical and research use. Alternative Names: (1-(piperidin-4-yl)-1H-pyrazol-4-yl)boronic acid. CAS No. 1146614-42-7. Molecular formula: C8H14BN3O2. Mole weight: 195.03. Catalog: APB1146614427. | |
| Crizotinib Impurity 13 | Crizotinib Impurity 13. Uses: For analytical and research use. CAS No. 2075-45-8. Molecular formula: C3H3BrN2. Mole weight: 146.97. Catalog: APB2075458. | |
| Crizotinib Impurity 14 | Crizotinib Impurity 14. Uses: For analytical and research use. CAS No. 3469-69-0. Molecular formula: C3H3IN2. Mole weight: 193.98. Catalog: APB3469690. | |
| Crizotinib Impurity 16 | Crizotinib Impurity 16. Uses: For analytical and research use. CAS No. 877399-73-0. Molecular formula: C13H20IN3O2. Mole weight: 377.23. Catalog: APB877399730. | |
| Crizotinib Impurity 19 | Crizotinib Impurity 19. Uses: For analytical and research use. CAS No. 1448326-33-7. Molecular formula: C13H10BrCl2FN2O. Mole weight: 380.04. Catalog: APB1448326337. | |
| Crizotinib Impurity 24 | Crizotinib Impurity 24. Uses: For analytical and research use. Molecular formula: C13H11Cl2FN2O2. Mole weight: 317.14. Catalog: APB07185. | |
| Crizotinib Impurity 26 | Crizotinib Impurity 26. Uses: For analytical and research use. CAS No. 1394346-24-7. Molecular formula: C13H8BrCl2FN2O3. Mole weight: 410.02. Catalog: APB1394346247. | |
| Crizotinib Impurity 3 | Crizotinib Impurity 3. Uses: For analytical and research use. Alternative Names: (R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-2-nitropyridine. CAS No. 877397-70-1. Molecular formula: C13H9Cl2FN2O3. Mole weight: 331.13. Catalog: APB877397701. | |
| Crizotinib Impurity 30 | Crizotinib Impurity 30. Uses: For analytical and research use. CAS No. 704-09-6. Molecular formula: C8H7Cl2FO. Mole weight: 209.04. Catalog: APB704096. | |
| Crizotinib Impurity 31 | Crizotinib Impurity 31. Uses: For analytical and research use. Molecular formula: C21H22Cl2FN5O2. Mole weight: 466.34. Catalog: APB07186. | |
| Crizotinib Impurity 32 | Crizotinib Impurity 32. Uses: For analytical and research use. Molecular formula: C21H20Cl2FN5O3. Mole weight: 480.32. Catalog: APB07187. | |
| Crizotinib Impurity 33 | Crizotinib Impurity 33. Uses: For analytical and research use. Molecular formula: C16H24N6. Mole weight: 300.41. Catalog: APB07188. | |
| Crizotinib Impurity 35 | Crizotinib Impurity 35. Uses: For analytical and research use. Molecular formula: C8H15BClN3O2. Mole weight: 231.49. Catalog: APB07190. | |
| Crizotinib Impurity 36 | Crizotinib Impurity 36. Uses: For analytical and research use. Molecular formula: C13H10BrCl2FN2O. Mole weight: 380.04. Catalog: APB07191. | |
| Crizotinib Impurity 37 | Crizotinib Impurity 37. Uses: For analytical and research use. Molecular formula: C13H10BrCl2FN2O. Mole weight: 380.04. Catalog: APB07189. | |
| Crizotinib Impurity 38 | Crizotinib Impurity 38. Uses: For analytical and research use. Molecular formula: C13H10BrCl2FN2O. Mole weight: 380.04. Catalog: APB07192. | |
Our database is helping our users find suppliers everyday.
